Sanofi offloads French rights for antipsychotic to neighboring pharma

Paul Schloesser

Associate Editor

Sanofi has handed off the French rights to anti-psych drug Teralithe to a small French pharma — both a divisible tablet and a prolonged-release tablet of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sanofi offloads French rights for antipsychotic to neighboring pharma

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

FTC to sue major PBMs over insulin rebates, claiming they inflated patient cost

Biotech VC firm outlines plans for $100M fund

Novo says its CB1 drug helped shed weight, but efficacy and safety questions remain

Why did Eli Lilly ask a patient on a compounded GLP-1 drug for their medical information?

FDA approves Zevra’s rare disease drug after resubmission

Breaking down silos with a new quantitative approach to drug development

Sanofi of­floads French rights for an­tipsy­chot­ic to neigh­bor­ing phar­ma

Associate Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Sanofi offloads French rights for antipsychotic to neighboring pharma